Elite Pharmaceuticals, Inc. Proceeds from (Repayments of) Short-term Debt
Elite Pharmaceuticals, Inc. (ELTP) reported Proceeds from (Repayments of) Short-term Debt of -$523.27 thousand for the 9-month period ending 2019-12-31, per its 10-Q filed 2020-02-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfShortTermDebt · last filed 2020-02-10
- Elite Pharmaceuticals, Inc. proceeds from (repayments of) short-term debt for the quarter ending 2019-12-31 was -$155.15K.
- Elite Pharmaceuticals, Inc. proceeds from (repayments of) short-term debt for the quarter ending 2019-09-30 was -$141.83K.
- Elite Pharmaceuticals, Inc. proceeds from (repayments of) short-term debt for the quarter ending 2019-06-30 was -$226.29K, a 221.64% decline year-over-year.
- Elite Pharmaceuticals, Inc. proceeds from (repayments of) short-term debt for the quarter ending 2019-03-31 was -$8.63K.
- Elite Pharmaceuticals, Inc. proceeds from (repayments of) short-term debt for fiscal 2019 was -$406.68K.
- Elite Pharmaceuticals, Inc. proceeds from (repayments of) short-term debt for fiscal 2018 was -$547.50K.
| Period end | Proceeds from (Repayments of) Short-term Debt 3 month | Proceeds from (Repayments of) Short-term Debt 6 month | Proceeds from (Repayments of) Short-term Debt 9 month | Proceeds from (Repayments of) Short-term Debt 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$155.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | -$296.98K derived: sum of 2 quarters · filed 2020-02-10 | -$523.27K 10-Q · filed 2020-02-10 | -$531.90K derived: sum of 4 quarters · filed 2020-02-10 |
| 2019-09-30 | -$141.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-12 | -$368.12K 10-Q · filed 2019-11-12 | -$376.76K derived: sum of 3 quarters · filed 2019-11-12 | -$386.04K derived: sum of 4 quarters · filed 2020-02-10 |
| 2019-06-30 | -$226.29K 10-Q · filed 2019-08-09 | -$234.93K derived: sum of 2 quarters · filed 2019-08-09 | -$244.20K derived: sum of 3 quarters · filed 2020-02-10 | -$819.00K derived: sum of 4 quarters · filed 2020-02-10 |
| 2019-03-31 | -$8.63K derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-21 | -$17.91K derived: sum of 2 quarters · filed 2020-02-10 | -$592.71K derived: sum of 3 quarters · filed 2020-02-10 | -$406.68K 10-K · filed 2019-06-21 |
| 2018-12-31 | -$9.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | -$584.08K derived: sum of 2 quarters · filed 2020-02-10 | -$398.05K 10-Q · filed 2020-02-10 | -$514.03K derived: sum of 4 quarters · filed 2020-02-10 |
| 2018-09-30 | -$574.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-12 | -$388.77K 10-Q · filed 2019-11-12 | -$504.76K derived: sum of 3 quarters · filed 2019-11-12 | -$675.83K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $186.03K 10-Q · filed 2019-08-09 | $70.04K derived: sum of 2 quarters · filed 2019-08-09 | -$101.03K derived: sum of 3 quarters · filed 2019-08-09 | -$200.94K derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | -$115.99K derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-21 | -$287.06K derived: sum of 2 quarters · filed 2019-06-21 | -$386.97K derived: sum of 3 quarters · filed 2019-06-21 | -$547.50K 10-K · filed 2019-06-21 |
| 2017-12-31 | -$171.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-11 | -$270.98K derived: sum of 2 quarters · filed 2019-02-11 | -$431.51K 10-Q · filed 2019-02-11 | |
| 2017-09-30 | -$99.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-09 | -$260.43K 10-Q · filed 2018-11-09 | ||
| 2017-06-30 | -$160.53K 10-Q · filed 2018-08-09 |